Cargando…
Surgical Management of Colorectal Liver Metastases: Prognostic Indicators and the Impact of RAS Mutation Status
Autores principales: | Wei, Steven H., Samp, Leigh A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803463/ https://www.ncbi.nlm.nih.gov/pubmed/27069738 |
Ejemplares similares
-
Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore
por: Baldin, Pamela, et al.
Publicado: (2020) -
Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study
por: Uutela, Aki, et al.
Publicado: (2022) -
Prognostic Models Incorporating RAS Mutation to Predict Survival in Patients with Colorectal Liver Metastases: A Narrative Review
por: Wong, Geoffrey Yuet Mun, et al.
Publicado: (2022) -
Implications of RAS Mutations on Oncological Outcomes of Surgical Resection and Thermal Ablation Techniques in the Treatment of Colorectal Liver Metastases
por: Rhaiem, Rami, et al.
Publicado: (2022) -
Current status of surgical treatment of colorectal liver metastases
por: Xu, Feng, et al.
Publicado: (2018)